Laxmi Organic Industries Limited has informed the Exchange about Transcript of Investor & Analyst Meet held on May 22, 2026, to discuss performance for the quarter and year ended March 31, 2026, hosted by Strategic Growth Advisors.
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Laxmi Organic reported a 9% sequential revenue growth in Q4 FY26 with margin improvements across both Essentials and Specialties businesses. However, full-year FY26 revenues declined 6% YoY due to deflationary feedstock pressures and the loss of a structural product contract contributing ~8-9% to the decline. The company has started dispatching from its new world-scale ethyl acetate plant at Lote, while Dahej Phase 2 chemical charging will begin in Q1 FY27 with revenues expected from H2 FY27. Acetic acid prices spiked above $700 in March-April due to Middle East conflict but have moderated to $450-470 currently, with ETAC spreads currently at $150-160. A new CFO, Amit Jain, will join from June 16, 2026. Management declined to provide specific revenue guidance for FY27-28 citing fluid macro conditions.
Mixed signals for investors: Q4 recovery is positive but FY26 full-year degrowth and ongoing margin pressures are concerns. Dahej Phase 2 ramp-up remains key growth driver for H2 FY27 and beyond, while logistics cost doubling could impact near-term profitability.